Literature DB >> 29164410

Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B.

Li-Yuan Wang1, Yu-Chen Fan1,2, Jing Zhao1, Xiang-Fen Ji1, Kai Wang3,4.   

Abstract

T helper (Th) 17 cells have a critical role in the pathogenesis of chronic hepatitis B virus (HBV) infection, and basic leucine zipper transcription factor, ATF-like (BATF) is a newly identified transcriptional factor regulating the differentiation of Th17 cells. However, its precise role in patients with chronic hepatitis B remains unclear. Sixty chronic hepatitis B (CHB) patients, twenty-two acute-on-chronic hepatitis B liver failure (ACHBLF) patients and seventeen healthy controls were included in our study. Both peripheral and intrahepatic expressions of BATF were analyzed by flow cytometry, quantitative real-time polymerase chain reaction and immunohistochemical staining. Peripheral BATF mRNA and protein expression levels were higher in CHB patients than those in healthy controls. Particularly in ACHBLF patients, the BATF mRNA and protein levels were further increased over those in CHB patients. Intrahepatic BATF-positive infiltrating cells were enriched in portal area of CHB patients, and more positive cells were found in patients with higher inflammation grade. Peripheral BATF expression was positively correlated with serum parameters of liver injury and plasma HBV DNA load. Furthermore, a positive correlation was found between the frequency of BATF-positive CD3+ T cells and the increased Th17 response in chronic HBV-infected patients. BATF over-expression might augment Th17 cell response and relate to the disease progression of CHB.

Entities:  

Keywords:  Basic leucine zipper transcription factor, ATF-like; Chronic hepatitis B; Interleukin-17; T helper 17

Mesh:

Substances:

Year:  2017        PMID: 29164410     DOI: 10.1007/s10238-017-0480-3

Source DB:  PubMed          Journal:  Clin Exp Med        ISSN: 1591-8890            Impact factor:   3.984


  48 in total

1.  Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1.

Authors:  N P Meyer; L M Johansen; H J Tae; P P Budde; K L Williams; E J Taparowsky
Journal:  Mamm Genome       Date:  1998-10       Impact factor: 2.957

2.  IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line.

Authors:  Bing Wang; Xin-Ping Zhao; Yu-Chen Fan; Jian-Jun Zhang; Jing Zhao; Kai Wang
Journal:  Antiviral Res       Date:  2012-12-27       Impact factor: 5.970

3.  Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells.

Authors:  Juan Liao; Sean E Humphrey; Stacie Poston; Elizabeth J Taparowsky
Journal:  Mol Cancer Res       Date:  2011-02-04       Impact factor: 5.852

Review 4.  Effects of hepatitis B virus X protein on the development of liver cancer.

Authors:  Xiaodong Zhang; Hang Zhang; Lihong Ye
Journal:  J Lab Clin Med       Date:  2006-02

5.  Stat3-dependent induction of BATF in M1 mouse myeloid leukemia cells.

Authors:  Takeshi Senga; Takashi Iwamoto; Sean E Humphrey; Takashi Yokota; Elizabeth J Taparowsky; Michinari Hamaguchi
Journal:  Oncogene       Date:  2002-11-21       Impact factor: 9.867

6.  Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.

Authors:  Ji-Yuan Zhang; Zheng Zhang; Fang Lin; Zheng-Sheng Zou; Ruo-Nan Xu; Lei Jin; Jun-Liang Fu; Feng Shi; Ming Shi; Hui-Fen Wang; Fu-Sheng Wang
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

7.  Implication of Th17 and Th1 cells in patients with chronic active hepatitis B.

Authors:  Jian Ge; Kai Wang; Qing-Hua Meng; Zhao-Xia Qi; Fan-Li Meng; Yu-Chen Fan
Journal:  J Clin Immunol       Date:  2009-09-10       Impact factor: 8.317

8.  A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes.

Authors:  Elke Glasmacher; Smita Agrawal; Abraham B Chang; Theresa L Murphy; Wenwen Zeng; Bryan Vander Lugt; Aly A Khan; Maria Ciofani; Chauncey J Spooner; Sascha Rutz; Jason Hackney; Roza Nurieva; Carlos R Escalante; Wenjun Ouyang; Dan R Littman; Kenneth M Murphy; Harinder Singh
Journal:  Science       Date:  2012-09-13       Impact factor: 47.728

9.  Hepatitis B virus X protein activates transcription factor NF-kappa B without a requirement for protein kinase C.

Authors:  R Lucito; R J Schneider
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

10.  Tim-3 expression on peripheral T cell subsets correlates with disease progression in hepatitis B infection.

Authors:  Wei Wu; Yu Shi; Jie Li; Feng Chen; Zhi Chen; Min Zheng
Journal:  Virol J       Date:  2011-03-11       Impact factor: 4.099

View more
  2 in total

1.  Hepatitis B core antibody and liver stiffness measurements predict HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients with minimally elevated alanine aminotransferase (ALT) levels.

Authors:  Xihua Fu; Haibo Lou; Fang Chen; Xueping Gao; Zhanzhou Lin
Journal:  Clin Exp Med       Date:  2020-02-12       Impact factor: 3.984

2.  Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients.

Authors:  Asmaa M Elbrolosy; Naglaa S Elabd; Gamalat A ElGedawy; Mai Abozeid; Mervat Abdelkreem; Belal Montaser; Emad M Eed; Moamena S Elhamouly
Journal:  Clin Exp Med       Date:  2022-02-04       Impact factor: 3.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.